End-of-day quote
Korea S.E.
03:30:00 14/05/2024 am IST
|
5-day change
|
1st Jan Change
|
4,250
KRW
|
+0.71%
|
|
+10.39%
|
+30.57%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,08,256
|
73,285
|
61,653
|
75,041
|
Enterprise Value (EV)
1 |
77,409
|
44,302
|
44,094
|
58,256
|
P/E ratio
|
20.3
x
|
22.6
x
|
13.8
x
|
20.7
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
4.61
x
|
2.8
x
|
1.59
x
|
1.57
x
|
EV / Revenue
|
3.3
x
|
1.69
x
|
1.13
x
|
1.22
x
|
EV / EBITDA
|
13.5
x
|
9.58
x
|
5.77
x
|
15.6
x
|
EV / FCF
|
40.8
x
|
13.2
x
|
6.6
x
|
15.2
x
|
FCF Yield
|
2.45%
|
7.59%
|
15.2%
|
6.59%
|
Price to Book
|
2.97
x
|
1.86
x
|
1.26
x
|
1.41
x
|
Nbr of stocks (in thousands)
|
22,263
|
22,636
|
23,048
|
23,054
|
Reference price
2 |
4,862
|
3,238
|
2,675
|
3,255
|
Announcement Date
|
12/03/21
|
11/03/22
|
22/03/23
|
15/03/24
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
23,489
|
26,153
|
38,874
|
47,844
|
EBITDA
1 |
5,750
|
4,623
|
7,635
|
3,737
|
EBIT
1 |
4,794
|
3,617
|
5,818
|
1,588
|
Operating Margin
|
20.41%
|
13.83%
|
14.97%
|
3.32%
|
Earnings before Tax (EBT)
1 |
4,900
|
3,945
|
5,155
|
4,406
|
Net income
1 |
4,854
|
3,229
|
4,405
|
3,739
|
Net margin
|
20.66%
|
12.35%
|
11.33%
|
7.81%
|
EPS
2 |
239.2
|
143.0
|
193.8
|
157.0
|
Free Cash Flow
1 |
1,898
|
3,364
|
6,683
|
3,837
|
FCF margin
|
8.08%
|
12.86%
|
17.19%
|
8.02%
|
FCF Conversion (EBITDA)
|
33%
|
72.77%
|
87.52%
|
102.68%
|
FCF Conversion (Net income)
|
39.1%
|
104.18%
|
151.69%
|
102.63%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/03/21
|
11/03/22
|
22/03/23
|
15/03/24
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
Net Cash position
1 |
30,847
|
28,983
|
17,559
|
16,786
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
1,898
|
3,364
|
6,683
|
3,837
|
ROE (net income / shareholders' equity)
|
20.6%
|
8.67%
|
10.2%
|
7.19%
|
ROA (Net income/ Total Assets)
|
8.14%
|
4.29%
|
5.4%
|
1.19%
|
Assets
1 |
59,626
|
75,204
|
81,586
|
3,13,857
|
Book Value Per Share
2 |
1,638
|
1,739
|
2,124
|
2,316
|
Cash Flow per Share
2 |
187.0
|
160.0
|
388.0
|
245.0
|
Capex
1 |
275
|
992
|
591
|
615
|
Capex / Sales
|
1.17%
|
3.79%
|
1.52%
|
1.29%
|
Announcement Date
|
12/03/21
|
11/03/22
|
22/03/23
|
15/03/24
|
|
1st Jan change
|
Capi.
|
---|
| +30.57% | 7.45Cr | | -15.96% | 856.91Cr | | +67.50% | 430.28Cr | | -4.03% | 246.23Cr | | -42.54% | 231.37Cr | | -6.49% | 193.23Cr | | -20.45% | 152.61Cr | | -41.24% | 120Cr | | +10.26% | 113.6Cr | | +18.74% | 99Cr |
Medical & Diagnostic Laboratories
|